RE: Spotlight Episode 13 has arrived!18 Dec 2025 18:59
Looks exciting. Some people seem to be representing the 'half life' of the peptide in the blood as a problem. What Christine is saying, quite clearly imo, is that that's the way the drug is designed. The drug locks into the tumour releasing it's full effect on impact with this tissue. Very little leaks into the blood stream or other organs or healthy cells. That way the drug can be more intense- other cancer drugs are very toxic causing all kinds of side effects, some of which can be very serious (cyk storms, cardiac issues etc). They can prolong this high impact treatment for 5 days at a time. Reducing the tumour size faster I assume?They have narrowed down the focus slightly because they have analysed the highest impact on the 5 cancers they first assessed to 4. It's almost as if a couple of people here want to misrepresent these findings to mislead investors? 😂
Anyway, looks brilliant to me. My brother has cancer. I hope they open up the opportunity for clinical trials far and wide.